You Find It

Intestinal Proteins May Be Effective Anti-Tumor Antigens

18:35 25-06-2008; source: www.sciencedaily.com

Mice immunized with an intestinal protein developed fewer lung and liver metastases following injection with colon cancer cells than unvaccinated animals, according to a study in the June 24 issue of the Journal of the National Cancer Institute.

Multiple Regions Of Chromosome 8 Found To Be Associated With Different Cancers

18:35 25-06-2008; source: www.sciencedaily.com

A recently discovered, but not yet understood, section of chromosome 8, called 8q24, may contain at least five distinct regions that are associated with different cancers, according to a study in the June 24 issue of the Journal of the National Cancer Institute.

NSAID Use Not Associated With Reduction In Melanoma Risk

18:35 25-06-2008; source: www.sciencedaily.com

The use of nonsteroidal anti-inflammatory drugs (NSAIDs) is not associated with a reduction in the risk of melanoma, according to the results of a large cohort study in the June 24 issue of the Journal of the National Cancer Institute.

New Glaucoma Procedure Aims To Prevent Further Eye Damage

18:35 25-06-2008; source: www.sciencedaily.com

Patients with glaucoma have a new treatment option known as the Trabectome. The minimally invasive procedure, which is available at Mayo Clinic and takes about 20 minutes, is designed to decrease pressure within the eye and stabilize the vision.

Bedsharing And Bassinets: Two New Studies Assess The Risks

15:35 25-06-2008; source: www.sciencedaily.com

Even though more than 45 percent of infants between the ages of 0-2 months use bassinets, little is known about bassinet safety. In 2005, the American Academy of Pediatrics revised its recommendations for a safe infant sleep environment, suggesting a separate but nearby sleeping arrangement. Two studies soon to be published in the Journal of Pediatrics evaluate the frequency of bedsharing and the potential risk factors of bassinet use.

Umbilical Cord Blood Cell Transplants May Help ALS Patients

15:35 25-06-2008; source: www.sciencedaily.com

Researchers transplanted human umbilical cord blood cells into mouse models with amyotrophic lateral sclerosis to determine which of three dose strength levels -- low, moderate and high -- delayed symptom progression and increased lifespan. Moderate strength doses of HUCB cells proved most effective and may have provided a neuroprotective effect for motor neurons through active involvement of the cells in modulating the host immune inflammatory system response.